What does Union Spring Pharmaceuticals invest in?
Union Spring Pharmaceuticals invests most often at Series D (100% of the rounds on record), in sectors such as Biotechnology, Clinical Trials and Pharmaceutical.
Last cheque observed Oct 2009. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietGrowth equity
2 rounds on record
Mostly Series D: 100% of its rounds
Every round we can evidence, newest first2 appearances
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as Union Spring Pharmaceuticals. A count of rooms they were both in, not a relationship either has claimed.
Union Spring Pharmaceuticals invests most often at Series D (100% of the rounds on record), in sectors such as Biotechnology, Clinical Trials and Pharmaceutical.
2 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2009.
The median round it joins is $63M.
No investments in the last 12 months; the latest was in Oct 2009.
Most often AIG Investments (2 rounds together), Aisling Capital (2 rounds together) and Blue Chip Venture Company (2 rounds together).
Union Spring Pharmaceuticals is a growth equity firm.
Union Spring Pharmaceuticals was founded in 2007.
From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it